Four Things Every Small Biotech Should Look for in a CRO Partner
Cari Kniola Senior Director, Corporate [...]
Demystifying the Decentralized Clinical Trial Part 3: Go Virtual With Your Clinical Trial
Demystifying the Decentralized Clinical Trial Part 3: Three Steps to [...]
Demystifying the Decentralized Clinical Trial Part 2: Risks & Benefits
Demystifying the Decentralized Clinical Trial Part 2: Risks and Benefits [...]
Aperio Joins Florence Healthcare on Live Webinar Panel “Moving Beyond COVID”
Your Content Goes Here Aperio’s Suzanne Kincaid [...]
Suzanne Kincaid to Present on Managing Risk in Clinical Research at MAGI’s Spring Conference
Your Content Goes Here Join [...]
Demystifying the Decentralized Clinical Trial Part 1: Taking on Terminology
Demystifying the Decentralized Clinical Trial Part I: Taking on Terminology [...]
PharmaVoice Sits Down with Aperio’s Suzanne Kincaid to Discuss Top Priorities in Clinical Research for 2021
Your Content Goes Here Check [...]
Six Essential Tips for Optimizing FDA GCP Inspection Outcomes – Part 3: Rigorous Program For Inspection Readiness and Management
Six Essential Tips for Optimizing FDA GCP Inspection Outcomes - [...]
Six Essential Tips for Optimizing FDA GCP Inspection Outcomes – Part 2 : The Inspection Readiness Plan, TMF Audit and BIMO Checklist
Six Essential Tips for Optimizing FDA GCP Inspection Outcomes - [...]
Cari Kniola Says Decentralized Clinical Trials Is the Next Big Game Changer
Your Content Goes Here Check [...]